The U.S. Food and Drug Administration in August 2022 approved dextromethorphan-bupropion, or Auvelity, a drug used to treat major depressive disorder, also known as clinical depression, in adults. It is the first drug to treat major depressive disorder that works within a week of taking it and is the first new pill to treat depression […]
The exact causes of anxiety disorders are unknown. According to the National Institute of Mental Health (NIMH)Trusted Source, a combination of genetic and environmental factors may play a role. Brain chemistry is also being studied as a possible cause. The areas of your brain that control your fear response may be involved. Anxiety disorders often […]
Major depressive disorder is the most widespread mood disorder in the world. Also called clinical depression, or just depression, it’s when you have symptoms of low mood or hopelessness for at least 2 weeks. Scientists still don’t know what causes it. But they know that treating it is complex and that people who have it […]
Depression and anxiety disorders cost the global economy US$1 trillion each year. Every US$ 1 invested in scaling up treatment for depression and anxiety leads to a return of US$ 4 in better health and ability to work, according to a new WHO-led study which estimates, for the first time, both the health and economic […]
In the first year of the COVID-19 pandemic, global prevalence of anxiety and depression increased by a massive 25%, according to a scientific brief released by the World Health Organization (WHO) today. The brief also highlights who has been most affected and summarizes the effect of the pandemic on the availability of mental health services […]